Abstract
In 26 patients, we evaluated a novel pulsed nasal delivery system for nitric oxide (NO) that, in the short term, was as effective as continuous delivery for decreasing pulmonary artery pressure and pulmonary vascular resistance. In 2 patients, NO delivered in the home using this pulsing system was well tolerated for up to 2 years. The long-term safety, efficacy, and acceptability of NO delivered in the home remains to be studied.
MeSH terms
-
Administration, Inhalation
-
Administration, Intranasal
-
Adolescent
-
Adult
-
Child
-
Child, Preschool
-
Female
-
Follow-Up Studies
-
Hemodynamics / drug effects*
-
Home Nursing / methods*
-
Humans
-
Hypertension, Pulmonary / drug therapy*
-
Hypertension, Pulmonary / physiopathology*
-
Male
-
Nitric Oxide / administration & dosage*
-
Pulse Therapy, Drug / instrumentation
-
Pulse Therapy, Drug / methods
-
Time
-
Treatment Outcome
-
Vasodilator Agents / administration & dosage*
Substances
-
Vasodilator Agents
-
Nitric Oxide